Impaired Eukaryotic Elongation Factor 1A Expression in Alzheimer's Disease.
CONCLUSION: Dysregulation of eEF1A and its associated signaling pathways might represent novel molecular mechanisms underlying AD pathogenesis. Further investigation is necessary to determine whether eEF1A is a viable therapeutic target for AD and other cognitive syndromes.
PMID: 26551858 [PubMed - as supplied by publisher]
Source: Neuro-Degenerative Diseases - Category: Neurology Authors: Beckelman BC, Zhou X, Keene CD, Ma T Tags: Neurodegener Dis Source Type: research
More News: Alzheimer's | Brain | Cerebellum | Learning | Neurology | Study | Universities & Medical Training